Profile
Anders H.
Pedersen was the founder of Profound Pharma AS, founded in 1999, where the title held was Director-Protein Chemistry from 1999 to 2009.
The current job is Chief Operating Officer at Galecto Biotech ApS, starting in 2013.
Former jobs include Manager-Projects & Department at Novo Nordisk A; Principal at The University of New Mexico from 1989 to 1990;.
Senior Vice President-Development at AGC Biologics A from 2010 to 2013; Chief Operating Officer at Recepticon ApS from 2006 to 2009; Manager-Project & Department at Biotech; Vice President-Portfolio Management at Life Cycle Pharma A from 2005 to 2006; and Chief Operating Officer at Galecto, Inc. from 2020 to 2026.
Education includes undergraduate studies at the Technical University of Denmark.
Anders Pedersen active positions
| Companies | Position | Start |
|---|---|---|
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Manufactures galectin modulators for the treatment of severe diseases which includes fibrosis and cancer | Chief Operating Officer | 2012-12-31 |
Former positions of Anders Pedersen
| Companies | Position | End |
|---|---|---|
| DAMORA THERAPEUTICS, INC. | Chief Operating Officer | 2026-01-04 |
AGC Biologics A/S
AGC Biologics A/S Pharmaceuticals: MajorHealth Technology Operates as a global contract process development and manufacturer of biopharmaceuticals | Corporate Officer/Principal | 2013-02-28 |
Recepticon ApS
Recepticon ApS Pharmaceuticals: MajorHealth Technology Develops receptor antagonists for prevention of medical induced organ damage | Chief Operating Officer | 2009-10-31 |
Life Cycle Pharma A/S | Corporate Officer/Principal | 2006-10-31 |
The University of New Mexico
The University of New Mexico Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 1989-12-31 |
Training of Anders Pedersen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Profound Pharma AS
Profound Pharma AS Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
The University of New Mexico
The University of New Mexico Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Technical University of Denmark
Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AGC Biologics A/S
AGC Biologics A/S Pharmaceuticals: MajorHealth Technology Operates as a global contract process development and manufacturer of biopharmaceuticals | Health Technology |
Recepticon ApS
Recepticon ApS Pharmaceuticals: MajorHealth Technology Develops receptor antagonists for prevention of medical induced organ damage | Health Technology |
Biotech
Biotech BiotechnologyHealth Technology Manufactures biotechnical products | Health Technology |
Life Cycle Pharma A/S | |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Manufactures galectin modulators for the treatment of severe diseases which includes fibrosis and cancer | Health Technology |
Galecto, Inc.
Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
- Stock Market
- Insiders
- Anders Pedersen
















